catalyst · primary record
BEVYXXA
Patent expiry · 2026-11-08 · BETRIXABAN
| Company | PORTOLA PHARMACEUTICALS INC |
|---|---|
| Ticker | Not stated |
| Impact | high |
| Detail | US 7598276 expires · BETRIXABAN |
| Source | FDA Orange Book |
Provenance
- Source: FDA Orange Book
- Fetched at: 2026-10-31T01:52:46.085Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: PORTOLA PHARMACEUTICALS INC:BEVYXXA:2026-11-08:US 7598276 expires · BETRIXABAN
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.